Navigation Links
Innovation and Medical Advances to be Highlighted on Final Day of Inaugural AdvaMed 2007 Conference
Date:10/3/2007

MedTech Conference Registration at 1,097

Keynote by George H.W. Bush Emphasizes Value of Medical Advances

WASHINGTON, Oct. 3 /PRNewswire-USNewswire/ -- AdvaMed 2007, the inaugural MedTech conference, will kick off its final day of programs with company presentations, panels focused on innovation and quality of life for patients, and a keynote address by former President George H.W. Bush, the 41st President of the United States.

Today, venture capitalists, investors, licensing officials, policy makers and others will hear more than 40 company presentations selected by the AdvaMed 2007 business development committee. Companies from 16 states and three countries, and at all stages of development, will present innovative technologies and intellectual property in the categories of Ophthalmology, Cardiovascular, Diagnostics, Imaging, Orthopedics, Wound Care and Additional Hot Topics. (Visit: http://www.advamed2007.com and click on the Business Development Forum page to see a complete overview of AdvaMed 2007 presenting companies.)

"The conference's theme today is 'Living Longer, Living Healthier,'" said Stephen J. Ubl, President and CEO of AdvaMed. "The presenting companies and keynote speaker today clearly showcase how innovations in medical technology such as hip, knee, and shoulder replacements, as well as advances in the diagnosis and treatment of cardiovascular disease, juvenile diabetes, and cancer allow individuals to live longer, healthier lives."

Former President George H.W. Bush, who had both hips replaced, will detail how medical advances have improved his life and the life of his family.

To view the full AdvaMed 2007 conference program visit http://www.AdvaMed2007.com

About AdvaMed:

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. Our members produce nearly 90 percent of the health care technology purchased annually in the United States and more than 50 percent purchased annually around the world. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit http://www.advamed.org.

About AdvaMed 2007:

AdvaMed 2007 is the premier medical technology conference and exhibition for business leaders, policymakers, investors, news media, patient advocates, and industry stakeholders from around the world. This year's conference offers a variety of workshops and panel discussions on subjects such as Medicare reimbursement, compliance, intellectual property, global market opportunities,

corporate finance, public policy, emerging company issues, 21st century health care and the value of medical technology.

Whether you need to finance, partner or license technology, AdvaMed 2007 introduces you to key decision-makers featuring a business development partnering program, company presentations, and an exhibition showcasing the latest medical technologies and products. Attendees have the opportunity to directly access key players, inform stakeholders as to the progress of our industry, and influence the business, political and financial climates so imperative to innovation.

For more information, visit http://www.AdvaMed2007.com or call 1-202-434- 7213.


'/>"/>
SOURCE AdvaMed; AdvaMed 2007
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Genetic innovation
2. Biocon To Shift Focus On Innovation To Accelerate Growth
3. IIT Delhi To Display Its Technological Innovations In Open House
4. Patent for Seminal RNAi innovation Cleared in Australia
5. Innovation Needed In The Field Of Diagnostics: Nair
6. A young scientist recognized for biomechanics innovations
7. Blood Safety, Supply, and Innovations Addressed at Conference
8. New Innovation in Clubfoot Treatment
9. Check if your “Favourite medical web-site” is indulging in Quackey
10. Teens turning to Internet for medical queries
11. Robots craft medical history
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ... committed to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne ... (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. , ...
(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is now accepting ... Invisalign® in Lutz, FL. With the help of this highly-effective, yet convenient system, ... potential complications, more discretion and less pain. , Drs. Sarah Jockin, Nicole Morganti, ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the thriving ... and head shops –can’t help but be heartened by the industry’s current surge. But ... aptly described as “skunk smell.” At last they can simply, safely and effectively ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
(Date:4/24/2017)... ... 24, 2017 , ... The Santana Telehealth Project was honored with the 2017 ... American Telemedicine Association’s annual conference, on April 23 in Orlando, FL. , “I am ... the lives of the poor and underserved in other parts of the world,” said ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: